Moflomycin is an anthracycline analogue that exhibits a higher antileukemic activity compared to other anthracyclines, such as daunorubicin and doxorubicin. The higher antileukemic activity of this compound are from greater stimulation of topoisomerase II-mediated DNA cleavage and higher molecular stability induced by the presence of an iodine atom. References: Andrivon W, Monneret C, Nafziger J, Florent JC, Guillosson JJ. A new anthracycline with potent anti-leukemic activity overcomes P-glycoprotein multidrug resistance. Leuk Res. 1998 Aug;22(8):719-25. PubMed PMID: 9680099.

纯度：≥98%

CAS：107430-03-5